1. Scrip
  2. >>Business

Finance Watch: Eleven Companies Reveal $1.45bn In $100m-Plus VC Deals

Venture Capital Boom Includes New Funds; OrbiMed Raises $3.5bn

 
• By Mandy Jackson

Private Company Edition: Clover’s $230m financing was the largest of recent mega-rounds. Century Therapeutics ($160m), Vividion ($135m) and eGenesis ($125m) also raised big rounds and investors Foresite Capital ($969m), Sofinnova Partners ($540m) and OMX Ventures ($150m) raised new VC funds. 

Finance Watch

Venture capital investment in biopharmaceuticals companies reached a new record in 2020 and in 2021 the pace of new financings remains robust with many large VC rounds. Venture capital firms also continue to raise significant new funds to back health care and life science investments, including OrbiMed with $3.5bn in new cash across three funds.

Eleven companies announced venture capital mega-rounds in a week and a half for a total of $1.45bn, from 22 February when Clover Biopharmaceuticals, Inc. revealed a $230m series C round through 3 March when Century Therapeutics, LLC said its series C round totaled $160m

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Financing

More from Business